Education
About Us
Working with TipRanks
Follow Us
Bioadaptives Inc (BDPT)
:BDPT
BDPT Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $0.13
Previous CloseN/A
Volume23.97K
Average Volume (3M)17.67K
Market Cap
$972.73K
Enterprise Value$1.25M
Total Cash (Recent Filing)$39.56K
Total Debt (Recent Filing)$343.10K
Price to Earnings (P/E)―
Beta3.09
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding9,048,659
10 Day Avg. Volume36,471
30 Day Avg. Volume17,668
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-0.60
Price to Sales (P/S)0.00
P/FCF Ratio-3.10
Enterprise Value/Market Cap1.29
Enterprise Value/Revenue8.44
Enterprise Value/Gross Profit528.96
Enterprise Value/Ebitda-0.39
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Options Prices
Currently, No data available
---
Ownership Overview
1.38% Insiders
―
Mutual Funds
― Other Institutional Investors
98.62% Public Companies and
Individual Investors
BDPT FAQ
What was Bioadaptives Inc’s price range in the past 12 months?
Bioadaptives Inc lowest stock price was <$0.01 and its highest was $0.13 in the past 12 months.
What is Bioadaptives Inc’s market cap?
Bioadaptives Inc’s market cap is $972.73K.
When is Bioadaptives Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Bioadaptives Inc’s earnings last quarter?
Currently, no data Available
Is Bioadaptives Inc overvalued?
According to Wall Street analysts Bioadaptives Inc’s price is currently Overvalued.
Does Bioadaptives Inc pay dividends?
Bioadaptives Inc does not currently pay dividends.
What is Bioadaptives Inc’s EPS estimate?
Bioadaptives Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bioadaptives Inc have?
Bioadaptives Inc has 9,048,659 shares outstanding.
What happened to Bioadaptives Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Bioadaptives Inc?
Currently, no hedge funds are holding shares in BDPT
---
Company Description
Bioadaptives Inc
BioAdaptives, Inc. markets and distributes natural plant and algal-based products for humans and animals. The company focuses on offering health and wellness products, such as dietary supplements. It offers PrimiCell, PluriPain, PrimiLungs, PrimiLive, and PrimiSleep, as well as markets Lung Flute for humans; Canine Regen and Equine Regen for dogs and horses, as well as base formulations, including Equine All-in-One to trainers, horse owners and boarding stables; and All-in-One products, which combine minerals, vitamins, amino acids, and other botanicals with the Regen compounds. The company was formerly known as APEX 8 Inc. and changed its name to BioAdaptives, Inc. in September 2013. BioAdaptives, Inc. was incorporated in 2013 and is based in Las Vegas, Nevada.
---
Technical Analysis
Herbalife
―
Natural Alternatives International
―
Nature's Sunshine Products
―
USANA Health
―
FitLife Brands
―
---